These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2586332)

  • 21. Serum inhibitory and bactericidal activity against methicillin-resistant Staphylococcus aureus in volunteers receiving novobiocin and rifampin alone and in combination.
    Standiford HC; Walsh TJ; Drusano GL; Tatem BA; Townsend RJ
    Diagn Microbiol Infect Dis; 1993; 17(2):135-42. PubMed ID: 8243034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bactericidal activity of oxacillin against beta-lactamase-hyperproducing Staphylococcus aureus.
    Woods GL; Yam P
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1614-8. PubMed ID: 3266987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
    Baiocchi P; Galiè M; Santini C; Carfagna P; Cassone M; Tarasi D; Venditti M
    J Chemother; 1998 Feb; 10(1):25-8. PubMed ID: 9531072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
    Røder BL; Gutschik E
    J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.
    Hackbarth CJ; Chambers HF; Sande MA
    Antimicrob Agents Chemother; 1986 Apr; 29(4):611-3. PubMed ID: 3707110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus.
    Van der Auwera P; Klastersky J
    Rev Infect Dis; 1983; 5 Suppl 3():S509-14. PubMed ID: 6635442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of oxacillin resistance in oxacillin-sensitive Staphylococcus aureus through exposure to ciprofloxacin but not piperacillin/tazobactam.
    Evans ME
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):621-3. PubMed ID: 12226696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.
    Van der Auwera P; Klastersky J
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1002-5. PubMed ID: 2959197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS; Morrison JO
    Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.
    Watanakunakorn C; Tisone JC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):920-2. PubMed ID: 7181497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
    Johnston BL; Kwok RY; Mulligan ME
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro.
    Sauermann R; Schwameis R; Fille M; Ligios ML; Zeitlinger M
    J Antimicrob Chemother; 2009 Oct; 64(4):821-3. PubMed ID: 19622535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial effects of vulgarone B from Artemisia iwayomogi alone and in combination with oxacillin.
    Chung EY; Byun YH; Shin EJ; Chung HS; Lee YH; Shin S
    Arch Pharm Res; 2009 Dec; 32(12):1711-9. PubMed ID: 20162399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.
    Van der Auwera P; Klastersky J
    Antimicrob Agents Chemother; 1986 Dec; 30(6):892-5. PubMed ID: 3813515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
    Van der Auwera P; Joly P
    J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activities of trimethoprim/sulfamethoxazole, 5-iodo-2'-deoxyuridine and rifampicin against Staphylococcus aureus.
    Zander J; Besier S; Faetke S; Saum SH; Müller V; Wichelhaus TA
    Int J Antimicrob Agents; 2010 Dec; 36(6):562-5. PubMed ID: 20947313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.
    Lorian V; Atkinson B; Kim Y
    Rev Infect Dis; 1983; 5 Suppl 3():S418-27. PubMed ID: 6556709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.
    Bamberger DM; Fields MT; Herndon BL
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2335-9. PubMed ID: 1804006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.
    Croes S; Beisser PS; Neef C; Bruggeman CA; Stobberingh EE
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3907-12. PubMed ID: 20606067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.